Incremental Haemodialysis in Incident Patients
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
- Principal Investigator
- Javier L Deira Lorenzo, PhD MDServicio Extremeño de Salud
- Intervention
- Incremental haemodialysis(procedure)
- Enrollment
- 152 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2025
Study locations (3)
- FundeSalud. Junta de Extremadura, Mérida, Badajoz, Spain
- Hospital Virgen del Puerto, Plasencia, Cáceres, Spain
- Hospital San Pedro de Alcántara, Cáceres, Spain
Collaborators
Hospital Arquitecto Marcide. Ferrol. A Coruña. (Spain) · Hospital San Pedro de Alcantara · Virgen del Puerto Hospital · Hospital Central de la Defensa Gómez Ulla. Madrid (Spain) · Hospital Costa del Sol · Hospital Obispo Polanco · Hospital de Manises. Valencia (Spain) · Hospital Virgen de la Concha. Zamora (Spain) · Hospital de Especialidades de las Fuerzas Armadas. Quito (Ecuador) · Servicio Extremeño de Salud (Spain) · Hospital del SAS de Jerez · Hospital Nuestra Sra de Sonsoles. Ávila (Spain) · Dialysis Center SM2. Potenza (Italy) · Miulli General Hospital · Hospital del Rio Hortega · Hospital Duran de Buenos Aires · Hospital El Bierzo · Hospitales Universitarios Virgen del Rocío · Hospital Universitario Virgen Macarena · University Hospital of Girona Dr. Josep Trueta
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03239808 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGPHASE2NCT07124078A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Incyte Corporation
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo